Trial drug can significantly block early stages of COVID-19 in engineered human tissues
Date: April 2, 2020 Source 1: University of British Columbia Source 2: www.sciencedaily.com Summary: An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks […]